Trouble Ahead For GLP-1 Drugs As Health Plans Stop Paying News June 9, 2026 More employers and health plans are balking at paying for costly GLP-1 drugs like Ozempic, Zepbound and Wegovy for weight…
GLP-1 Weight Loss Drugs Could Stop Cancer Progressing Says New Study Tech May 25, 2026 GLP-1 medications such as Wegovy, Ozempic and Mounjaro have already transformed treatment for obesity and Type 2 diabetes. Now, emerging…
Employer Co-Pays For GLP-1 Weight Loss Drugs To Rise If They’re Covered Tech May 24, 2026 The latest report on rising employer healthcare costs shows GLP-1 weight loss drugs like Ozempic, Zepbound and Wegovy are the…